GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ESPR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Esperion Therapeutics stock price on Thursday which ended trading at $1.87
(Updated on Apr 18, 2024)

Sell candidate since Apr 11, 2024 Loss -19.05% PDF

The Esperion Therapeutics stock price gained 1.63% on the last trading day (Thursday, 18th Apr 2024), rising from $1.84 to $1.87. During the last trading day the stock fluctuated 12.15% from a day low at $1.81 to a day high of $2.03. The price has fallen in 8 of the last 10 days and is down by -39.87% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $11.22 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.64% during the next 3 months and, with a 90% probability hold a price between $1.95 and $3.45 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ESPR Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 1.63%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Esperion Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.08 and $2.40. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Esperion Therapeutics stock

Esperion Therapeutics finds support from accumulated volume at $1.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.220 between high and low, or 12.15%. For the last week, the stock has had daily average volatility of 11.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ESPR) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Esperion Therapeutics to open at $1.90, and during the day (based on 14 day Average True Range), to move between $1.59 and $2.15, which gives a possible trading interval of +/-$0.277 (+/-14.83%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 29.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.84 (1.60%) than the resistance at $2.02 (8.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Esperion Therapeutics stock A Buy?

The Esperion Therapeutics stock holds several negative signals and despite the positive trend, we believe Esperion Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.041 Sell Candidate Unchanged

Predicted Opening Price for Esperion Therapeutics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.90 ( 1.78%) $1.87

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ESPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.12 13.55 %
R2 2.04 9.05 %
R1 1.99 6.28 %
Current price: 1.87
Support S1 1.82 -2.71 %
S2 1.77 -5.49 %
S3 1.68 -9.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.14 14.44 %
R2 2.07 10.70 %
R1 2.02 8.02 %
Current price 1.87
Support S1 1.84 -1.60%
S2 0 .
S3 0 .

FAQ

What is the symbol for Esperion Therapeutics Stock and on which exchange is it traded?
The symbol for Esperion Therapeutics is ESPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Esperion Therapeutics Stock?
The Esperion Therapeutics stock holds several negative signals and despite the positive trend, we believe Esperion Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Esperion Therapeutics Stock?
Esperion Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Esperion Therapeutics Stock.

What's the current price of Esperion Therapeutics Stock?
As of the end of day on the 2024-04-18, the price of an Esperion Therapeutics (ESPR) share was $1.87.

What is the 52-week high and low for Esperion Therapeutics Stock?
The 52-week high for Esperion Therapeutics Stock is $3.40 and the 52-week low is $0.700.

What is the market capitalization of Esperion Therapeutics Stock?
As of the 2024-04-18, the market capitalization of Esperion Therapeutics is 318.682M.

When is the next earnings date for Esperion Therapeutics?
The upcoming earnings date for Esperion Therapeutics is May 14, 2024.
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT